Skip to content
‹ Back to IndustriesHealthcare

Catching Up With George Stringer of Soraa at LFI 2018

One of the industry leaders to set up a booth at last week’s LightFair 2018 conference in Chicago, IL was Soraa. We stopped to speak with their Senior Vice-President of Sales and Marketing, George Stringer. “The nice thing about LightFair this year is that we were selected as one of the top ten booths to…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

One of the industry leaders to set up a booth at last week’s LightFair 2018 conference in Chicago, IL was Soraa. We stopped to speak with their Senior Vice-President of Sales and Marketing, George Stringer.

“The nice thing about LightFair this year is that we were selected as one of the top ten booths to see because of an award-winning product,” Stringer said. “People forget that we’re a technology company first. We’re a semiconductor company. We make violet based semiconductors in Freemont, California, because we believe that natural light should mirror what the sunlight does.”

For Soraa, there is an understanding that to meet their customers’ needs, the technology must be perfected before applications and products are even discussed. It is this dedication to the small details that has made them so popular with companies who crave the aesthetic provided by natural light.

“The people who care most about color quality would be museums, retail, high end, residential and hospitality. Those are the markets that we cater to,” Stringer said. “We’ve started focusing primarily on retail because that’s where light and color really matter.”

Stringer stopped to show us one of their cutting-edge designs, the Radiant GU10. It is a directional light that allows for proper lighting in spaces where display is essential.

“Museums are a critical vertical for us. If you think about what they’re trying to do in terms of color for the artwork and sculptures – if you’re going to have beautiful antiquities and art you want to light them with the best color quality of light,” he said. “I would say we’ve done close to 300 museums in North America alone,” Stringer noted.

Internationally, the company has a strong presence as well. Soraa’s products even light up the Palace of Versailles. Stringer believes much of this success is simply because they listen to what customers are asking for and find ways to make that a reality. When more lumens were required, they found a way to develop fixtures with more design freedom to incorporate heat sinks. And when it was discovered that violet light can be used to get rid of unwanted bacteria, the company began to develop innovative concepts using the technology they already had at their disposal.

“We found that we can increase the output of violet light to 405 nanometers and kill most of the bacteria in an eight-hour period,” Stringer said. “Violet has many purposes, it renders white, it gives better color, it gives a healthy light solution and it has medical applications for bacteria removal. We’re doing all of that for technology today, but also for products for the future.”

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Humana's $2.8B BlackRock deal lets it buy back CenterWell clinics starting in 2028

Humana's $2.8B BlackRock deal lets it buy back CenterWell clinics starting in 2028

BlackRock's $2.8 billion buys majority ownership of a joint venture holding about 150 CenterWell clinics, replacing WCAS as Humana's outside investor. CenterWell keeps a minority stake and keeps running the clinics. The terms set a timeline: two years of expected growth spending, an option for Humana to buy clinics back from 2028, and a BlackRock right to start a sale of any clinics still in the venture at the end of 2033, with CenterWell getting the first offer. The deal is expected to close in the fourth quarter, subject to regulatory approvals.

  • 01BlackRock's $2.8 billion buys majority ownership of about 150 CenterWell clinics, while Humana keeps day-to-day management and an option to repurchase clinics starting in 2028.
  • 02The 2028 buyback and 2033 sale terms apply to the roughly 150 clinics in the new joint venture. CenterWell Senior Primary Care runs 250 clinics in total.
  • 03The deal’s lower-cost-of-capital claim will be tested after closing—first by how the venture deploys new capital over the next two years to support clinics, open locations and pursue acquisitions, and then by Humana’s 2028 decision on whether to start buying clinics back.

Nov 12, 2026

Healthcare AI should give doctors attention back, not shorter visits

Healthcare AI should give doctors attention back, not shorter visits

Healthcare organizations should deploy AI to give clinicians back attention and capacity for better decisions, not simply shorten visits. Landry argues AI should fit into existing workflows with insights appearing at the right time, and that organizations should set clear governance and automation boundaries before deployment and measure what changes for patients, clinicians and the organization.

  • 01AI success in healthcare should expand clinician capacity for thoughtful care, not optimize for visit speed; a three-minute appointment is not patient-centered innovation.
  • 02Design AI into workflows clinicians already use with insights appearing at the right moment, making adoption a workflow problem rather than a training problem.
  • 03Set automation boundaries before deploying AI, specifying what it may do alone, what it recommends for clinician decision-making, and what requires explicit human control and accountability.

Nov 11, 2026

Black Book: AI may make some outsourced health plan work cheaper to bring in-house

Black Book: AI may make some outsourced health plan work cheaper to bring in-house

U.S. health plan administrative costs rose 2.7% to about $69.2 billion in the first half of 2026, even as margins improved to 4.1%. Black Book Research's 2027 outlook says AI is starting to move payer sourcing in both directions. Demand for specialist vendors stays strong in some functions, while automation could make in-house or hybrid models viable in others. The report recommends comparing each major outsourced service with rival vendors and the best internal or hybrid option, and checking whether projected savings become actual cash.

  • 01Every major outsourced payer service should be benchmarked against a rival vendor and against the plan's best feasible internal or hybrid model, a three-way contest at each renewal.
  • 02Staffing reductions, payment recoveries, avoided vacancies and productivity improvements may not translate into recurring cash, so plans shouldn’t assume outsourcing savings can fund AI until the service, AI and funding cases are evaluated separately.
  • 03Provider data sits on both sides of the sourcing question: it is a top pain point and a specialist-demand area, yet also one of the functions where automation could make hybrid or in-house models viable.

Nov 11, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512